| Year |
Citation |
Score |
| 2020 |
Yates JWT, Byrne H, Chapman SC, Chen T, Cucurull-Sanchez L, Delgado-SanMartin J, Di Veroli G, Dovedi SJ, Dunlop C, Jena R, Jodrell D, Martin E, Mercier F, Ramos-Montoya A, Struemper H, ... Vicini P, et al. Opportunities for quantitative translational modelling in Oncology. Clinical Pharmacology and Therapeutics. PMID 32569424 DOI: 10.1002/Cpt.1963 |
0.362 |
|
| 2019 |
Milberg O, Gong C, Jafarnejad M, Bartelink IH, Wang B, Vicini P, Narwal R, Roskos L, Popel AS. A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade. Scientific Reports. 9: 11286. PMID 31375756 DOI: 10.1038/S41598-019-47802-4 |
0.318 |
|
| 2019 |
Jafarnejad M, Gong C, Gabrielson E, Bartelink IH, Vicini P, Wang B, Narwal R, Roskos L, Popel AS. A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer. The Aaps Journal. 21: 79. PMID 31236847 DOI: 10.1208/S12248-019-0350-X |
0.323 |
|
| 2019 |
Wang H, Milberg O, Bartelink IH, Vicini P, Wang B, Narwal R, Roskos L, Santa-Maria CA, Popel AS. simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model. Royal Society Open Science. 6: 190366. PMID 31218069 DOI: 10.1098/Rsos.190366 |
0.306 |
|
| 2018 |
Gong C, Anders RA, Zhu Q, Taube JM, Green B, Cheng W, Bartelink IH, Vicini P, Wang B, Popel AS. Quantitative Characterization of CD8+ T Cell Clustering and Spatial Heterogeneity in Solid Tumors. Frontiers in Oncology. 8: 649. PMID 30666298 DOI: 10.3389/Fonc.2018.00649 |
0.301 |
|
| 2018 |
Bartelink IH, Jones EF, Shahidi-Latham SK, Rong ELP, Zheng Y, Vicini P, van 't Veer L, Wolf D, Iagaru A, Kroetz DL, Prideaux B, Cilliers C, Thurber G, Wimana Z, Gebhart G. Tumor drug penetration measurements could be the neglected piece of the personalized cancer treatment puzzle. Clinical Pharmacology and Therapeutics. PMID 30107040 DOI: 10.1002/Cpt.1211 |
0.32 |
|
| 2017 |
Baverel PG, Dubois VFS, Jin CY, Zheng Y, Song X, Jin X, Mukhopadhyay P, Gupta A, Dennis PA, Ben Y, Vicini P, Roskos L, Narwal R. Population Pharmacokinetics of Durvalumab in Cancer Patients and Association with Longitudinal Biomarkers of Disease Status. Clinical Pharmacology and Therapeutics. PMID 29243223 DOI: 10.1002/Cpt.982 |
0.354 |
|
| 2017 |
Darwich AS, Ogungbenro K, Vinks AA, Powell JR, Reny JL, Marsousi N, Daali Y, Fairman D, Cook J, Lesko LJ, McCune JS, Knibbe CA, de Wildt SN, Leeder JS, Neely M, ... ... Vicini P, et al. Why has model-informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future. Clinical Pharmacology and Therapeutics. PMID 28182269 DOI: 10.1002/Cpt.659 |
0.3 |
|
| 2017 |
Milberg O, Gong C, Wang B, Vicini P, Narwal R, Roskos L, Popel A. Abstract 4531: Systems pharmacology to predict cellular biomarkers and optimize mono- and combination-therapy regimens: Focusing on immune checkpoint targets PD-1, PD-L1 and CTLA-4 Cancer Research. 77: 4531-4531. DOI: 10.1158/1538-7445.Am2017-4531 |
0.334 |
|
| 2016 |
Spilker ME, Chen X, Visswanathan R, Vage C, Yamazaki S, Li GG, Lucas J, Bradshaw-Pierce EL, Vicini P. Found in Translation: Maximizing the Clinical Relevance of Nonclinical Oncology Studies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27551002 DOI: 10.1158/1078-0432.Ccr-16-1164 |
0.674 |
|
| 2016 |
Yankeelov TE, An G, Saut O, Luebeck EG, Popel AS, Ribba B, Vicini P, Zhou X, Weis JA, Ye K, Genin GM. Multi-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success. Annals of Biomedical Engineering. PMID 27384942 DOI: 10.1007/S10439-016-1691-6 |
0.315 |
|
| 2016 |
Clancy CE, An G, Cannon WR, Liu Y, May EE, Ortoleva P, Popel AS, Sluka JP, Su J, Vicini P, Zhou X, Eckmann DM. Multiscale Modeling in the Clinic: Drug Design and Development. Annals of Biomedical Engineering. PMID 26885640 DOI: 10.1007/S10439-016-1563-0 |
0.336 |
|
| 2016 |
Yamazaki S, Spilker ME, Vicini P. Translational modeling and simulation approaches for molecularly targeted small molecule anticancer agents from bench to bedside. Expert Opinion On Drug Metabolism & Toxicology. 12: 253-65. PMID 26799750 DOI: 10.1517/17425255.2016.1141895 |
0.672 |
|
| 2016 |
Spilker ME, Singh P, Vicini P. Mathematical modeling of receptor occupancy data: A valuable technology for biotherapeutic drug development. Cytometry. Part B, Clinical Cytometry. 90: 230-6. PMID 26296748 DOI: 10.1002/Cyto.B.21318 |
0.666 |
|
| 2015 |
Yamazaki S, Lam JL, Zou HY, Wang H, Smeal T, Vicini P. Mechanistic understanding of translational pharmacokinetic-pharmacodynamic relationships in nonclinical tumor models: a case study of orally available novel inhibitors of anaplastic lymphoma kinase. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 43: 54-62. PMID 25349124 DOI: 10.1124/Dmd.114.061143 |
0.319 |
|
| 2015 |
Nayak S, Lee D, Arkin S, Martin SW, Heatherington AC, Denney WS, Vicini P, Hua F. A Quantitative Systems Pharmacology Model for the Coagulation Network Describes Biomarker Changes Observed in a Clinical Study with FXa Variant and Predicts Age-Associated Biomarker Variations Blood. 126: 3502-3502. DOI: 10.1182/Blood.V126.23.3502.3502 |
0.335 |
|
| 2014 |
Hickling TP, Chen X, Vicini P, Nayak S. A review of quantitative modeling of B cell responses to antigenic challenge. Journal of Pharmacokinetics and Pharmacodynamics. 41: 445-59. PMID 25326873 DOI: 10.1007/S10928-014-9388-7 |
0.303 |
|
| 2014 |
Yamazaki S, Lam JL, Zou HY, Wang H, Smeal T, Vicini P. Translational pharmacokinetic-pharmacodynamic modeling for an orally available novel inhibitor of anaplastic lymphoma kinase and c-Ros oncogene 1. The Journal of Pharmacology and Experimental Therapeutics. 351: 67-76. PMID 25073473 DOI: 10.1124/Jpet.114.217141 |
0.344 |
|
| 2013 |
Palsson S, Hickling TP, Bradshaw-Pierce EL, Zager M, Jooss K, O'Brien PJ, Spilker ME, Palsson BO, Vicini P. The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset models. Bmc Systems Biology. 7: 95. PMID 24074340 DOI: 10.1186/1752-0509-7-95 |
0.666 |
|
| 2013 |
Chen X, Hickling T, Kraynov E, Kuang B, Parng C, Vicini P. A mathematical model of the effect of immunogenicity on therapeutic protein pharmacokinetics. The Aaps Journal. 15: 1141-54. PMID 23990500 DOI: 10.1208/S12248-013-9517-Z |
0.356 |
|
| 2013 |
Luu KT, Kraynov E, Kuang B, Vicini P, Zhong WZ. Modeling, simulation, and translation framework for the preclinical development of monoclonal antibodies. The Aaps Journal. 15: 551-8. PMID 23408094 DOI: 10.1208/S12248-013-9464-8 |
0.307 |
|
| 2012 |
Yamazaki S, Vicini P, Shen Z, Zou HY, Lee J, Li Q, Christensen JG, Smith BJ, Shetty B. Pharmacokinetic/pharmacodynamic modeling of crizotinib for anaplastic lymphoma kinase inhibition and antitumor efficacy in human tumor xenograft mouse models. The Journal of Pharmacology and Experimental Therapeutics. 340: 549-57. PMID 22129595 DOI: 10.1124/Jpet.111.188870 |
0.325 |
|
| 2011 |
Yamazaki S, Nguyen L, Vekich S, Shen Z, Yin MJ, Mehta PP, Kung PP, Vicini P. Pharmacokinetic-pharmacodynamic modeling of biomarker response and tumor growth inhibition to an orally available heat shock protein 90 inhibitor in a human tumor xenograft mouse model. The Journal of Pharmacology and Experimental Therapeutics. 338: 964-73. PMID 21680888 DOI: 10.1124/Jpet.111.181339 |
0.321 |
|
| 2010 |
Vicini P. Multiscale modeling in drug discovery and development: future opportunities and present challenges. Clinical Pharmacology and Therapeutics. 88: 126-9. PMID 20520608 DOI: 10.1038/Clpt.2010.87 |
0.308 |
|
| 2010 |
Roper RT, Pia Saccomani M, Vicini P. Cellular signaling identifiability analysis: a case study. Journal of Theoretical Biology. 264: 528-37. PMID 20188743 DOI: 10.1016/J.Jtbi.2010.02.029 |
0.335 |
|
| 2010 |
Denti P, Bertoldo A, Vicini P, Cobelli C. IVGTT glucose minimal model covariate selection by nonlinear mixed-effects approach. American Journal of Physiology. Endocrinology and Metabolism. 298: E950-60. PMID 20103736 DOI: 10.1152/Ajpendo.00656.2009 |
0.353 |
|
| 2010 |
Salinger DH, Vicini P, Blough DK, O'Donnell PV, Pawlikowski MA, McCune JS. Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration. Journal of Clinical Pharmacology. 50: 1292-300. PMID 20075185 DOI: 10.1177/0091270009357430 |
0.342 |
|
| 2010 |
Spilker ME, Yamazaki S, Blasina A, Hallin J, Bartkowski DM, Vicini P. Abstract 3601: Evaluation of a mathematical modeling framework to describe combination therapy with Gemcitabine Cancer Research. 70: 3601-3601. DOI: 10.1158/1538-7445.Am10-3601 |
0.341 |
|
| 2009 |
Luu KT, Zhang EY, Prasanna G, Xiang C, Anderson S, Fortner J, Vicini P. Pharmacokinetic-pharmacodynamic and response sensitization modeling of the intraocular pressure-lowering effect of the EP4 Agonist 5-{3-[(2S)-2-{(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]butyl}-5-oxopyrrolidin-1-yl]propyl}thiophene-2-carboxylate (PF-04475270). The Journal of Pharmacology and Experimental Therapeutics. 331: 627-35. PMID 19690190 DOI: 10.1124/Jpet.109.157800 |
0.323 |
|
| 2009 |
Denti P, Bertoldo A, Vicini P, Cobelli C. Nonlinear mixed effects to improve glucose minimal model parameter estimation: a simulation study in intensive and sparse sampling. Ieee Transactions On Bio-Medical Engineering. 56: 2156-66. PMID 19380266 DOI: 10.1109/Tbme.2009.2020171 |
0.337 |
|
| 2009 |
McCune JS, Salinger DH, Vicini P, Oglesby C, Blough DK, Park JR. Population pharmacokinetics of cyclophosphamide and metabolites in children with neuroblastoma: a report from the Children's Oncology Group. Journal of Clinical Pharmacology. 49: 88-102. PMID 18927240 DOI: 10.1177/0091270008325928 |
0.312 |
|
| 2008 |
Seng KY, Glenny RW, Madtes DK, Spilker ME, Vicini P, Gharib SA. Comparison of statistical data models for identifying differentially expressed genes using a generalized likelihood ratio test. Gene Regulation and Systems Biology. 2: 125-139. PMID 19119428 DOI: 10.4137/Grsb.S381 |
0.646 |
|
| 2008 |
Vicini P, Brill AB, Stabin MG, Rescigno A. Kinetic modeling in support of radionuclide dose assessment. Seminars in Nuclear Medicine. 38: 335-46. PMID 18662555 DOI: 10.1053/J.Semnuclmed.2008.05.007 |
0.32 |
|
| 2008 |
Zierhut ML, Gastonguay MR, Martin SW, Vicini P, Bekker PJ, Holloway D, Leese PT, Peterson MC. Population PK-PD model for Fc-osteoprotegerin in healthy postmenopausal women. Journal of Pharmacokinetics and Pharmacodynamics. 35: 379-99. PMID 18633695 DOI: 10.1007/S10928-008-9093-5 |
0.323 |
|
| 2008 |
Seng KY, Nestorov I, Vicini P. Physiologically based pharmacokinetic modeling of drug disposition in rat and human: a fuzzy arithmetic approach. Pharmaceutical Research. 25: 1771-81. PMID 18363078 DOI: 10.1007/S11095-007-9447-5 |
0.303 |
|
| 2008 |
Krudys KM, Greenbaum CJ, Pihoker C, Vicini P. Use of oral glucose minimal model-derived index of insulin sensitivity in subjects with early type 1 diabetes mellitus. Metabolism: Clinical and Experimental. 57: 445-7. PMID 18328342 DOI: 10.1016/J.Metabol.2007.10.001 |
0.32 |
|
| 2007 |
Zhou Q, Guo P, Kruh GD, Vicini P, Wang X, Gallo JM. Predicting human tumor drug concentrations from a preclinical pharmacokinetic model of temozolomide brain disposition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 4271-9. PMID 17634557 DOI: 10.1158/1078-0432.Ccr-07-0658 |
0.309 |
|
| 2007 |
Zierhut ML, Gardner JC, Spilker ME, Sharp JT, Vicini P. Kinetic modeling of contrast-enhanced MRI: an automated technique for assessing inflammation in the rheumatoid arthritis wrist. Annals of Biomedical Engineering. 35: 781-95. PMID 17340197 DOI: 10.1007/S10439-006-9249-7 |
0.655 |
|
| 2007 |
Hebert MF, Naraharisetti SB, Ma X, Krudys KM, Umans J, Hankins GDV, Caritis S, Miodovnik M, Mattison DR, Unadkat J, Easterling TR, Vicini P. 53: Are we guessing glyburide dosage in the treatment of gestational diabetes (GDM)? The pharmacological evidence for better clinical practice American Journal of Obstetrics and Gynecology. 197. DOI: 10.1016/J.Ajog.2007.10.060 |
0.307 |
|
| 2006 |
Krudys KM, Kahn SE, Vicini P. Population approaches to estimate minimal model indexes of insulin sensitivity and glucose effectiveness using full and reduced sampling schedules. American Journal of Physiology. Endocrinology and Metabolism. 291: E716-23. PMID 16954338 DOI: 10.1152/Ajpendo.00346.2005 |
0.315 |
|
| 2006 |
Keenan TM, Hooker A, Spilker ME, Li N, Boggy GJ, Vicini P, Folch A. Automated identification of axonal growth cones in time-lapse image sequences. Journal of Neuroscience Methods. 151: 232-8. PMID 16174535 DOI: 10.1016/J.Jneumeth.2005.07.010 |
0.624 |
|
| 2006 |
Bertoldo A, Vicini P, Cobelli C. THE GLUCOSE MINIMAL MODEL: POPULATION VS INDIVIDUAL PARAMETER ESTIMATION Ifac Proceedings Volumes. 39: 231-235. DOI: 10.3182/20060920-3-Fr-2912.00044 |
0.343 |
|
| 2005 |
Spilker ME, Seng KY, Yao AA, Daldrup-Link HE, Shames DM, Brasch RC, Vicini P. Mixture model approach to tumor classification based on pharmacokinetic measures of tumor permeability. Journal of Magnetic Resonance Imaging : Jmri. 22: 549-58. PMID 16161077 DOI: 10.1002/Jmri.20412 |
0.657 |
|
| 2005 |
Krudys KM, Dodds MG, Nissen SM, Vicini P. Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT. American Journal of Physiology. Endocrinology and Metabolism. 288: E1038-46. PMID 15632105 DOI: 10.1152/Ajpendo.00058.2004 |
0.343 |
|
| 2004 |
Gallo JM, Vicini P, Orlansky A, Li S, Zhou F, Ma J, Pulfer S, Bookman MA, Guo P. Pharmacokinetic model-predicted anticancer drug concentrations in human tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8048-58. PMID 15585640 DOI: 10.1158/1078-0432.Ccr-04-0822 |
0.337 |
|
| 2004 |
Dodds MG, Vicini P. Assessing convergence of Markov chain Monte Carlo simulations in hierarchical Bayesian models for population pharmacokinetics. Annals of Biomedical Engineering. 32: 1300-13. PMID 15493516 DOI: 10.1114/B:Abme.0000039363.94089.08 |
0.306 |
|
| 2003 |
Østerberg O, Erichsen L, Ingwersen SH, Plum A, Poulsen HE, Vicini P. Pharmacokinetic and pharmacodynamic properties of insulin aspart and human insulin. Journal of Pharmacokinetics and Pharmacodynamics. 30: 221-35. PMID 14571692 DOI: 10.1023/A:1025594110558 |
0.34 |
|
| 2003 |
Agersø H, Vicini P. Pharmacodynamics of NN2211, a novel long acting GLP-1 derivative. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 19: 141-50. PMID 12791417 DOI: 10.1016/S0928-0987(03)00073-3 |
0.322 |
|
| 2003 |
Kerwin W, Hooker A, Spilker M, Vicini P, Ferguson M, Hatsukami T, Yuan C. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation. 107: 851-6. PMID 12591755 DOI: 10.1161/01.Cir.0000048145.52309.31 |
0.628 |
|
| 2002 |
Vicini P, Gastonguay MR, Foster DM. Model-based approaches to biomarker discovery and evaluation: a multidisciplinary integrated review. Critical Reviews in Biomedical Engineering. 30: 379-418. PMID 12739755 DOI: 10.1615/Critrevbiomedeng.V30.I456.60 |
0.369 |
|
| 2002 |
Vicini P, Avogaro A, Spilker ME, Gallo A, Cobelli C. Epinephrine effects on insulin-glucose dynamics: the labeled IVGTT two-compartment minimal model approach. American Journal of Physiology. Endocrinology and Metabolism. 283: E78-84. PMID 12067846 DOI: 10.1152/Ajpendo.00530.2001 |
0.669 |
|
| 2001 |
Spilker ME, Vicini P. An evaluation of extended vs weighted least squares for parameter estimation in physiological modeling. Journal of Biomedical Informatics. 34: 348-64. PMID 12123152 DOI: 10.1006/Jbin.2001.1033 |
0.669 |
|
| 2001 |
Vicini P, Cobelli C. The iterative two-stage population approach to IVGTT minimal modeling: improved precision with reduced sampling. Intravenous glucose tolerance test. American Journal of Physiology. Endocrinology and Metabolism. 280: E179-86. PMID 11120672 DOI: 10.1152/Ajpendo.2001.280.1.E179 |
0.342 |
|
| 2000 |
Vicini P, Pierce CH, Dills RL, Morgan MS, Kalman DA. Individual prior information in a physiological model of 2H8-toluene kinetics: an empirical Bayes estimation strategy. Risk Analysis : An Official Publication of the Society For Risk Analysis. 19: 1127-34. PMID 10765452 DOI: 10.1023/A:1007034712016 |
0.338 |
|
| 1999 |
Caumo A, Vicini P, Zachwieja JJ, Avogaro A, Yarasheski K, Bier DM, Cobelli C. Undermodeling affects minimal model indexes: insights from a two-compartment model. The American Journal of Physiology. 276: E1171-93. PMID 10362630 DOI: 10.1152/Ajpendo.1999.276.6.E1171 |
0.327 |
|
| 1999 |
Vicini P, Cobelli C. A priori identifiability of distributed models of blood-tissue exchange. Annals of Biomedical Engineering. 27: 200-7. PMID 10199697 DOI: 10.1114/1.174 |
0.326 |
|
| 1999 |
Vicini P, Zachwieja JJ, Yarasheski KE, Bier DM, Caumo A, Cobelli C. Glucose production during an IVGTT by deconvolution: validation with the tracer-to-tracee clamp technique. The American Journal of Physiology. 276: E285-94. PMID 9950788 DOI: 10.1152/Ajpendo.1999.276.2.E285 |
0.335 |
|
| 1999 |
Vicini P, Caumo A, Cobelli C. Glucose effectiveness and insulin sensitivity from the minimal models: consequences of undermodeling assessed by Monte Carlo simulation. Ieee Transactions On Bio-Medical Engineering. 46: 130-7. PMID 9932334 DOI: 10.1109/10.740875 |
0.33 |
|
| 1999 |
Bertoldo A, Vicini P, Sambuceti G, Lammertsma AA, Parodi O, Cobelli C. Evaluation of compartmental and spectral analysis models of [18F]FDG kinetics for heart and brain studies with PET. Ieee Transactions On Bio-Medical Engineering. 45: 1429-48. PMID 9835192 DOI: 10.1109/10.730437 |
0.303 |
|
| 1999 |
Vicini P, Pierce CH, Dills RL, Morgan MS, Kalman DA. Individual Prior Information in a Physiological Model of 2H8-Toluene Kinetics: An Empirical Bayes Estimation Strategy Risk Analysis. 19: 1127-1134. DOI: 10.1111/J.1539-6924.1999.Tb01133.X |
0.332 |
|
| 1998 |
Heatherington AC, Vicini P, Golde H. A pharmacokinetic/pharmacodynamic comparison of SAAM II and PC/WinNonlin modeling software Journal of Pharmaceutical Sciences. 87: 1255-1263. PMID 9758686 DOI: 10.1021/Js9603562 |
0.336 |
|
| 1998 |
Barrett PH, Bell BM, Cobelli C, Golde H, Schumitzky A, Vicini P, Foster DM. SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. Metabolism: Clinical and Experimental. 47: 484-92. PMID 9550550 DOI: 10.1016/S0026-0495(98)90064-6 |
0.315 |
|
| 1998 |
Hoffman RP, Vicini P, Sivitz WI, Cobelli C. Determinants of Insulin Sensitivity and Glucose Effectiveness in Early Puberty from the One and Two Compartment Models † 439 Pediatric Research. 43: 78-78. DOI: 10.1203/00006450-199804001-00460 |
0.316 |
|
| 1997 |
Vicini P, Caumo A, Cobelli C. The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity. American Journal of Physiology. Endocrinology and Metabolism. 273: E1024-E1032. PMID 29585506 DOI: 10.1152/Ajpendo.1997.273.5.E1024 |
0.302 |
|
| 1997 |
Sparacino G, Vicini P, Bonadonna R, Marraccini P, Lehtovirta M, Ferrannini E, Cobelli C. Removal of catheter distortion in multiple indicator dilution studies: a deconvolution-based method and case studies on glucose blood-tissue exchange. Medical & Biological Engineering & Computing. 35: 337-42. PMID 9327609 DOI: 10.1007/Bf02534087 |
0.306 |
|
| 1997 |
Vicini P, Cobelli C. Parameter estimation in distributed models of blood-tissue exchange: a Monte Carlo strategy to assess precision. Annals of Biomedical Engineering. 25: 815-21. PMID 9300105 DOI: 10.1007/Bf02684165 |
0.309 |
|
| 1997 |
Vicini P, Sparacino G, Caumo A, Cobelli C. Estimation of endogenous glucose production after a glucose perturbation by nonparametric stochastic deconvolution. Computer Methods and Programs in Biomedicine. 52: 147-56. PMID 9051338 DOI: 10.1016/S0169-2607(96)01784-1 |
0.311 |
|
| 1997 |
Caumo A, Vicini P, Cobelli C. Is the minimal model too minimal? Diabetologia. 39: 997-1000. PMID 8858225 DOI: 10.1007/Bf00403922 |
0.304 |
|
| 1997 |
Caumo A, Vicini P, Cobelli C. Minimal Models of Glucose Disappearance: Effect of Undermodeling Assessed by Monte Carlo Simulation Ifac Proceedings Volumes. 30: 89-90. DOI: 10.1016/S1474-6670(17)44548-4 |
0.35 |
|
| 1996 |
Avogaro A, Vicini P, Valerio A, Caumo A, Cobelli C. The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects. The American Journal of Physiology. 270: E532-40. PMID 8638702 DOI: 10.1152/Ajpendo.1996.270.3.E532 |
0.336 |
|
| 1994 |
Vicini P, Pasinato S, Saccomani MP, Cobelli C, Frascerra S, Pecori N, Ferrannini E, Bonadonna RC. A Multi-Region Distributed Model of Glucose Kinetics in the Human Myocardium Ifac Proceedings Volumes. 27: 241-242. DOI: 10.1016/S1474-6670(17)46219-7 |
0.318 |
|
| Show low-probability matches. |